<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Q318 SCS Market Recap: On Track for Another Record Year

1/21/19 10:17 AM

Q318 SCS MarketNew Products, Continued Demand Provide SCS Market Tailwinds

SmartTRAK reports that with new products providing a strong tailwind in Q318, the SCS market saw another quarter of strong double-digit growth in both the US and WW, positioning the market for another record year. 

Among the many topics covered in the Q318 SCS Market Recap are:

  • Market Overview
  • Abbott’s Slowdown Continues
  • What’s Next?
  • Boston Scientific Going Strong on WaveWriter
  • DBS Ramping Up
  • Medtronic Accelerates
  • Nevro’s Growth Decelerates
  • A Skeptical Wall Street
  • Strategies for Growth
  • Who’s Next?
  • Q318 Regulatory and Clinical Highlights

According to SmartTRAK, YTD in 2018, the US SCS market grew +21.1% vs the same time period in 2017 , while the WW SCS market reached...

Read the entire Q318 SCS Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info


Topics: Neuro Therapies

Anne Staylor
Written by Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

    Recent Articles